Prolonged and selective induction of Fos-related antigen(s) in striatal neurons after 6-hydroxydopamine lesions of the rat substantia nigra pars compacta.

[1]  M. Dragunow,et al.  D2 dopamine receptor antagonists induce fos and related proteins in rat striatal neurons , 1990, Neuroscience.

[2]  B. McEwen,et al.  Increase in striatal dopamine D2 receptor mRNA after lesions of haloperidol treatment. , 1990, European journal of pharmacology.

[3]  H. Tilson,et al.  Influence of nigrostriatal dopaminergic tone on the biosynthesis of dynorphin and enkephalin in rat striatum. , 1990, Brain research. Molecular brain research.

[4]  X.-T. Hu,et al.  Lesions of the nigrostriatal dopamine projection increase the inhibitory effects of D1 and D2 dopamine agonists on caudate-putamen neurons and relieve D2 receptors from the necessity of D1 receptor stimulation , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[5]  A. Nieoullon,et al.  Somatostatin-immunoreactive neurons in the rat striatum: effects of corticostriatal and nigrostriatal dopaminergic lesions , 1990, Brain Research.

[6]  H. Iba,et al.  Isolation and characterization of fra-2, an additional member of the fos gene family. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[7]  A. Crossman,et al.  Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. I. 6-OHDA lesions of ascending mesencephalic dopaminergic pathways in the rat , 1990, Brain Research.

[8]  T. Curran,et al.  Regulation of proenkephalin by Fos and Jun. , 1989, Science.

[9]  G. Robertson,et al.  D1-dopamine receptor agonists selectively activate striatal c-fos independent of rotational behaviour , 1989, Brain Research.

[10]  R. Roth,et al.  Effects of dopamine depletion on striatal neurotensin: biochemical and immunohistochemical studies , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[11]  M. Dragunow,et al.  L-dopa activates c-fos in the striatum ipsilateral to a 6-hydroxydopamine lesion of the substantia nigra. , 1989, European journal of pharmacology.

[12]  L. Kerkérian,et al.  Pharmacological characterization of dopaminergic influence on expression of neuropeptide Y immunoreactivity by rat striatal neurons , 1988, Neuroscience.

[13]  T. Curran,et al.  fra-1: a serum-inducible, cellular immediate-early gene that encodes a fos-related antigen , 1988, Molecular and cellular biology.

[14]  M. Dragunow,et al.  Localization and induction of c-fos protein-like immunoreactive material in the nuclei of adult mammalian neurons , 1988, Brain Research.

[15]  B. Franza,et al.  Analysis of Fos protein complexes and Fos-related antigens by high-resolution two-dimensional gel electrophoresis. , 1987, Oncogene.

[16]  D. Pfaff,et al.  Haloperidol increases proenkephalin mRNA levels in the caudate-putamen of the rat: a quantitative study at the cellular level using in situ hybridization. , 1987, Brain research.

[17]  R. Bravo,et al.  Wounding a fibroblast monolayer results in the rapid induction of the c‐fos proto‐oncogene. , 1986, The EMBO journal.